Literature DB >> 2326256

Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies.

L B DeMonte1, P Nistico, R Tecce, P Dellabona, M Momo, A Anichini, M Mariani, P G Natali, F Malavasi.   

Abstract

The present study reports on the use of gene transfer by retrovirus-derived shuttle vectors in the generation of hybrid hybridomas secreting bispecific monoclonal antibodies. neo- and dhfr- genes were infected into distinct murine hybridomas, thus conferring a dominant resistance trait to geneticin (G418) and to methotrexate. The vectors employed were replication-deficient and dependent on complementation by a helper virus provided by the irradiated packaging lines. After cocultivation with the relevant packaging cell lines, stable hybridoma lines expressing the selectable markers were easily obtained and were then suitable for conventional somatic fusion. This high-efficiency method was used to generate two bispecific monoclonal antibodies simultaneously targeting molecules expressed on cytotoxic cells (i.e., T lymphocytes and natural killer cells) against a human melanoma-associated antigen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2326256      PMCID: PMC53809          DOI: 10.1073/pnas.87.8.2941

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Murine monoclonal antibodies as probes for the phenotypical, functional, and molecular analysis of a discrete peripheral blood lymphocyte population exerting natural killer activity in vitro.

Authors:  F Malavasi; G Bellone; L Matera; C Milanese; E Ferrero; A Funaro; S Demaria; F Caligaris-Cappio; G Camussi; P Dellabona
Journal:  Hum Immunol       Date:  1985-10       Impact factor: 2.850

2.  Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene.

Authors:  A D Miller; M F Law; I M Verma
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

3.  Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.

Authors:  R Orlandi; D H Güssow; P T Jones; G Winter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction.

Authors:  A Anichini; A Mazzocchi; G Fossati; G Parmiani
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

5.  Hybrid hybridomas and their use in immunohistochemistry.

Authors:  C Milstein; A C Cuello
Journal:  Nature       Date:  1983 Oct 6-12       Impact factor: 49.962

6.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

7.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

8.  Microplate selection technique (MPST). A new method for selecting mouse transfectants expressing human gene products.

Authors:  L Peruzzi; G Melioli; L B De Monte; M Alessio; M Zaccolo; S Roggero; G Bellone; A Funaro; F Malavasi
Journal:  J Immunol Methods       Date:  1989-09-29       Impact factor: 2.303

9.  Gene expression in mice after high efficiency retroviral-mediated gene transfer.

Authors:  M A Eglitis; P Kantoff; E Gilboa; W F Anderson
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

10.  Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies.

Authors:  P Perez; R W Hoffman; J A Titus; D M Segal
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more
  5 in total

1.  Generation of human monoclonal antibodies that confer protection against pertussis toxin.

Authors:  M Zaccolo; S Roggero; D Armellini; L Pegoraro; R Rappuoli; F Malavasi
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Biosensor analysis of antigen-antibody interactions as a priority step in the generation of monoclonal bispecific antibodies.

Authors:  A Horenstein; C Poiesi; M Camagna; L de Monte; M Mariani; A Albertini; F Malavasi
Journal:  Cell Biophys       Date:  1994

3.  Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma.

Authors:  P Nisticò; R Mortarini; L B De Monte; A Mazzocchi; M Mariani; F Malavasi; G Parmiani; P G Natali; A Anichini
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

4.  A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in Candida Species.

Authors:  Andrea Zito; Carla Bromuro; Giorgia Mandili; Paola Chiani; Alberto L Horenstein; Fabio Malavasi; Roberto Cauda; Antonio Cassone; Antonella Torosantucci
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

5.  Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex.

Authors:  M Thome; P Duplay; M Guttinger; O Acuto
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.